alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
HomeOffice of the SpokespersonPress Releases...Department of State Dedicates New U.S. Consulate General in Dhahran, Kingdom of Saudi Arabia

# 									Department of State Dedicates New U.S. Consulate General in Dhahran, Kingdom of Saudi Arabia							

Media Note

Office of the Spokesperson

November 29, 2022

In an important symbol of our partnership with the Kingdom of Saudi Arabia, Deputy Assistant Secretary of State for Arabian Peninsula Affairs Daniel Benaim, U.S. Embassy Riyadh Chargé d’Affaires Martina Strong, and U.S. Consul General in Dhahran David Edginton officially dedicated the new U.S. Consulate General campus in Dhahran.

The new campus is situated on a 10.5-acre site in the Al Andalus District in the city of Al-Khobar and incorporates numerous sustainable features to conserve resources and reduce operating costs, including demand-controlled ventilation, efficient site lighting, and on-site wastewater treatment and reuse. It achieved Leadership in Energy and Environmental Design (LEED®) Silver certification—a globally recognized mark of achievement in high-performance, best-in-class, green buildings.

Skidmore, Owings & Merrill, LLP of Washington, D.C., was the design architect for the project, and Caddell Construction Company, LLC of Montgomery, Alabama, constructed the complex, employing a workforce of roughly 800 U.S., Saudi Arabian, and third-country nationals and injecting approximately $95 million into the local economy.

Learn more about the project.

Since the start of the Department’s Capital Security Construction Program in 1999, Overseas Buildings Operations (OBO) has completed 173 new diplomatic facilities. OBO currently has more than 50 active projects in the design phase or under construction worldwide.

OBO provides safe, secure, functional, and resilient facilities that represent the U.S. government to the host nation and that support U.S. diplomats in advancing U.S. foreign policy objectives abroad.

For further information, please contact OBO External Affairs Director Neda Brown at OBO-External-Affairs@state.gov or visit www.state.gov/obo.

Tags

Building OperationsBureau of Near Eastern AffairsConsulatesOffice of the SpokespersonBureau of Overseas Buildings OperationsSaudi Arabia

Back to Top
#### § 137.297 If the environmental review procedures of a Federal agency are adopted by a Self-Governance Tribe, is the Self-Governance Tribe responsible for ensuring the agency's policies and procedures meet the requirements of NEPA, NHPA, and related environmental laws?

No, the Federal agency is responsible for ensuring its own policies and procedures meet the requirements of NEPA, NHPA, and related environmental laws, not the Self-Governance Tribe.
HomeEcuador

# Ecuador

128 items

        -    		Overseas Business Insights, August-September, 2018	  August 1, 2018 
        -    Report  		Ecuador	  June 28, 2018 
        -    Report  		Ecuador	  May 29, 2018 
        -    Report  		Ecuador	  April 20, 2018 
        -    		Overseas Business Insights, December, 2017	  December 1, 2017 
        -    TIAS  		Ecuador (17-912.1) – Extension to Annex I of Agreement of September 26, 1986, as modified	  September 12, 2017 
        -    Air Transport Agreement  		U.S. Diplomatic Note Extending Annex I to U.S.-Ecuador Air Transport Agreement of September 12, 2017	  September 12, 2017 
        -    Air Transport Agreement  		Ecuador Diplomatic Note Extending Annex I to U.S.-Ecuador Air Transport Agreement of August 29, 2017	  August 29, 2017 
        -    Report  		Ecuador	  August 15, 2017 
        -    Report  		Ecuador	  June 29, 2017 

previous page1…10111213next page

Back to Top
#### § 800.217 Entity.

The term *entity* means any branch, partnership, group or sub-group, association, estate, trust, corporation or division of a corporation, or organization (whether or not organized under the laws of any State or foreign state); assets (whether or not organized as a separate legal entity) operated by any one of the foregoing as a business undertaking in a particular location or for particular products or services; and any government (including a foreign national or subnational government, the U.S. Government, a subnational government within the United States, and any of their respective departments, agencies, or instrumentalities). (See examples in § 800.301(g)(5) through (14) and § 800.302(g)(5) through (10).)
#### § 137.401 What role does Tribal consultation play in the IHS annual budget request process?

The IHS will consult with Tribes on budget issues consistent with Administration policy on Tribal consultation.
Exhibit 31.2

CERTIFICATION



I, Robert W. McMartin, certify that:

1.

I have reviewed this Report on Form 10-QSB of Circuit Research Labs, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(c)

Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and

5.

The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably



---

likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.

Date:  December 29, 2006.



/s/ Robert W. McMartin

Robert W. McMartin

Chief Financial Officer
#### Stevens v. Fentech Industries, Inc.

Case No. 89AP729

Franklin County, (10th)

Decided February 6, 1990

[Cite as 1 AOA 413]

*Simmons, Meyer & Kart, and Mr. Louis F. Kort, for appellee.*

*Ms. Patricia A. Jamison, for appellants.*

BOWMAN, J.

This dispute between a contractor and a subcontractor was referred to arbitration pursuant to Loe. R. 65 of the Court of Common Pleas of Franklin County, General Division. After a hearing, the arbitration report and award was filed granting judgment to appellee. On May 15, 1989, appellants filed a timely notice of appeal of the arbitration award in the court of common pleas. On May 17, 1989, the trial court entered judgment on the arbitration award.

Appellants now bring this appeal an assert the following assignment of error:

> "The trial court erred in entering judgment upon the arbitration award after defendant-appellant had filed a timely notice of appeal to the trial court pursuant to Rule 65.15, Rules of Practice of the Court of Common Pleas."

Loe. R. 65.15 of the Court of Common Pleas of Franklin County General Division, provides:

> "(A) *Right of Appeal De Novo.*Any party may appeal from the award of the Board of the Common Pleas Court. * * * The filing of a single appeal shall be sufficient to require a *de novo*trial of the entire case on all issues and as to all parties without the necessity of each party filing a separate appeal. * * *

> «* * *

> "(2) * * * After perfection of the appeal, the case shall be returned to the assigned judge for trial.

> "(B) * * * All cases which have been duly appealed shall be tried *de novo.** * *"

Appellants timely filed their notice of appeal, including the affidavit stating that the appeal was not taken for delay, but because the party believed an injustice had been done as required by Loe. R. 65.15(AMlXa). In accordance with the local rule, the case should have been returned to the trial court judge who should have held a trial *de novo*on the entire case on all issues and as to all parties. Loe. R. 65.15(B) mandates that all cases which have been appealed *shall*be tried *de novo.*

Accordingly, the trial court erred in not complying with its own local rule and in not holding a trial *de novo*on all the issues as to all parties and in entering judgment on the arbitration award. Accordingly, appellants' assignment of error is well-taken.

Appellants' assignment of error is sustained and the judgment of the trial court is reversed.

This cause is remanded to the trial court, to comply with Loe. R. 65.15 of the court of Common Pleas of Franklin County, General Division, who shall hold a trial *de novo*on all issues and as to all parties.

*Judgment reversed and cause remanded*

YOUNG and HOFSTETTER, JJ., Concur.

HOFSTETTER, J., retired of the Eleventh Appellate District, assigned to active duty under authority of Section 6(C), Article IV, Ohio Constitution.
§ 802.802 Confidentiality. ( a ) Except as provided in paragraph (b) of this section, any information or documentary material submitted or filed with the Committee under this part, including information or documentary material filed under § 802.501(g), shall be exempt from disclosure under the Freedom of Information Act, as amended (5 U.S.C. 552 *et seq.*), and no such information or documentary material may be made public.
( b ) Paragraph (a) of this section shall not prohibit disclosure of the following: ( 1 ) Information relevant to any administrative or judicial action or proceeding;
( 2 ) Information to Congress or to any duly authorized committee or subcommittee of Congress;
( 3 ) Information important to the national security analysis or actions of the Committee to any domestic governmental entity, or to any foreign governmental entity of a United States ally or partner, under the exclusive direction and authorization of the Chairperson, only to the extent necessary for national security purposes, and subject to appropriate confidentiality and classification requirements; or
( 4 ) Information that the parties have consented to be disclosed to third parties;
( c ) This section shall continue to apply with respect to information and documentary material submitted or filed with the Committee in any case where: ( 1 ) Action has concluded under section 721 concerning a notified transaction;
( 2 ) A request to withdraw a notice or a declaration is granted under § 802.509 or § 802.404(c), respectively, or where a notice or a declaration has been rejected under § 802.504(a) or § 802.404(a), respectively;
( 3 ) The Committee determines that a notified or declared transaction is not a covered real estate transaction; or
( 4 ) Such information or documentary material was filed under subpart D and the parties do not subsequently file a notice under subpart E.
( d ) Nothing in paragraph (a) of this section shall be interpreted to prohibit the public disclosure by a party of documentary material or information that it has submitted or filed with the Committee. Any such documentary material or information so disclosed may subsequently be reflected in the public statements of the Chairperson, who is authorized to communicate with the public and the Congress on behalf of the Committee, or of the Chairperson's designee.
( e ) The provisions of the Defense Production Act Reauthorization of 2003, as amended (50 U.S.C. 4555(d)) relating to fines and imprisonment shall apply with respect to the disclosure of information or documentary material filed with the Committee under these regulations.
#### § 801.301 Control.

For the sole purpose of determining whether a transaction could result in control of a pilot program U.S. business by a foreign person, the provisions set forth in subpart C of this part (excluding § 800.302(b) of this chapter and the examples thereunder) regarding covered transactions shall apply to any pilot program covered transaction declared to the Committee pursuant to § 801.401 or notified to the Committee pursuant to § 801.501.
#### SOUTHERN TACKLE DISTRIBUTORS, INC., a Florida corporation, Appellant, v. JACK ECKERD CORPORATION, a Florida corporation, Appellee.

No. 74-796.

District Court of Appeal of Florida, Third District.

Aug. 14, 1974.

PER CURIAM.

Appeal dismissed.
HomeRomania

# Romania

148 items

        -    Media Note  		Visit of a Delegation from the Organization for the Prohibition of Chemical Weapons Executive Council Visit, June 12-14, 2023	  June 12, 2023Richmond, Kentucky / Washington, D.C. 
        -    Remarks  		Ambassador-at-Large for Global Women’s Issues Dr. Geeta Gupta's Remarks at the Fifth Annual Capital Level Meeting of the Women, Peace and Security Focal Points Network Ministerial Lunch	  Geeta Rao GuptaJune 7, 2023Hotel ViceroyWashington, D.C. 
        -    Notice to the Press  		United States and Romania Host Fifth Capital-Level Meeting of the Women, Peace, and Security Focal Points Network, with Opening Plenary Session at the Department of State	  June 5, 2023 
        -    DipNote  		Transatlantic Fellow Program Deepens Bonds Between United States and Europe	  June 2, 2023 
        -    Media Note  		The United States and Multinational Public-Private Partners Look to Provide Up To $275 Million to Advance the Romania Small Modular Reactor Project; United States Issues Letters of Interest for Up To $4 Billion in Project Financing	  May 20, 2023 
        -    Report  		2022 Report on International Religious Freedom: Romania	  May 15, 2023 
        -    Media Note  		Deputy Secretary for Management and Resources Verma’s Travel to Poland, Moldova, and Romania	  May 14, 2023 
        -    Media Note  		United States Supports Education and Training of Next Generation Advanced Civil Nuclear Workforce through Launch of Small Modular Reactor Control Room Simulator in Romania	  May 12, 2023 
        -    Media Note  		Release of the 2023 Annual Report on International Parental Child Abduction	  May 2, 2023 
        -    Report  		2022 Country Reports on Human Rights Practices: Romania	  March 20, 2023 

previous page123456…15next page

Back to Top
HomeIran

# Iran

595 items

        -    Media Note  		Joint Statement by the Secretary of State of the United States of America and the EU High Representative for Foreign Affairs and Security Policy/ Vice President of the European Commission	  March 24, 2021 
        -    Department Press Briefing  		Department Press Briefing – March 22, 2021	  Jalina PorterMarch 22, 2021 
        -    Department Press Briefing  		Department Press Briefing – March 18, 2021	  Jalina PorterMarch 18, 2021Washington, D.C. 
        -    Department Press Briefing  		Department Press Briefing – March 17, 2021	  Jalina PorterMarch 17, 2021Washington, D.C. 
        -    Department Press Briefing  		Department Press Briefing – March 11, 2021	  Ned PriceMarch 11, 2021Washington, D.C. 
        -    Department Press Briefing  		Department Press Briefing – March 9, 2021	  Ned PriceMarch 9, 2021Washington, D.C.  
        -    Press Statement  		Designation of Iranian Officials Due to Involvement in Gross Violations of Human Rights	  Antony J. BlinkenMarch 9, 2021 
        -    Press Statement  		Fourteenth Anniversary of Robert “Bob” Levinson’s Abduction	  Antony J. BlinkenMarch 9, 2021 
        -    Department Press Briefing  		Department Press Briefing – March 8, 2021	  Ned PriceMarch 8, 2021Washington, D.C.  
        -    Department Press Briefing  		Department Press Briefing – March 5, 2021	  Ned PriceMarch 5, 2021Washington, D.C.  

previous page1…5354555657…60next page

Back to Top
§ 405.201 Scope of subpart and definitions. ( a ) *Scope.* This subpart establishes that— ( 1 ) CMS uses the FDA categorization of a device as a factor in making Medicare coverage decisions; and
( 2 ) CMS may consider for Medicare coverage certain devices with an FDA-approved investigational device exemption (IDE) that have been categorized as Category B (Nonexperimental/investigational) device.
( 3 ) CMS identifies criteria for coverage of items and services furnished in IDE studies.
( b ) *Definitions.* As used in this subpart— *Category A (Experimental) device* refers to a device for which “absolute risk” of the device type has not been established (that is, initial questions of safety and effectiveness have not been resolved) and the FDA is unsure whether the device type can be safe and effective.
*Category B (Nonexperimental/investigational) device* refers to a device for which the incremental risk is the primary risk in question (that is, initial questions of safety and effectiveness of that device type have been resolved), or it is known that the device type can be safe and effective because, for example, other manufacturers have obtained FDA premarket approval or clearance for that device type.
*ClinicalTrials.gov* refers to the National Institutes of Health's National Library of Medicine's online registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.
*Contractors* refers to Medicare Administrative Contractors and other entities that contract with CMS to review and adjudicate claims for Medicare payment of items and services.
*Investigational device exemption (IDE)* refers to an FDA-approved IDE application that permits a device, which would otherwise be subject to marketing approval or clearance, to be shipped lawfully for the purpose of conducting a clinical study in accordance with 21 U.S.C. 360j(g) and 21 CFR part 812.
*Routine care items and services* refers to items and services that are otherwise generally available to Medicare beneficiaries (that is, a benefit category exists, it is not statutorily excluded, and there is no national noncoverage decision) that are furnished during a clinical study and that would be otherwise furnished even if the beneficiary were not enrolled in a clinical study.
[60 FR 48423, Sept. 19, 1995, as amended at 78 FR 74809, Dec. 10, 2013; 86 FR 3009, Jan. 14, 2021; 86 FR 62958, Nov. 15, 2021]
#### § 136.407 Under what circumstances should a conviction, or plea of nolo contendere or guilty to, be considered if there has been a pardon, expungement, set aside, or other court order of the conviction or plea?

All convictions or pleas of nolo contendere or guilty to should be considered in making a determination unless a pardon, expungement, set aside or other court order reaches the plea of guilty, plea of nolo contendere, or the finding of guilt.
Exhibit 32.1



Certification of Periodic Financial Report Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350



In connection with the Quarterly Report of First Capital Institutional Real Estate, Ltd.-2 (the
Partnership) on Form 10-Q for the quarter ending September 30, 2003 as filed with the Securities and Exchange Commission on the date hereof (the Report), each of Donald J. Liebentritt, as President and Chief Executive Officer
of First Capital Financial, L.L.C., the General Partner of the Partnership (the General Partner), and Philip Tinkler, as Vice PresidentFinance and Treasurer of the General Partner, hereby certifies, pursuant to 18 U.S.C. 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Partnership.
| | --- | -------------------------------------------------------------------------------------------------------------------------------------------------------



/s/    DONALD J. LIEBENTRITTDONALD J. LIEBENTRITT President and Chief Executive
Officer November 12, 2003




/s/    PHILIP TINKLERPHILIP TINKLER Vice PresidentFinance and
Treasurer November 12, 2003
§ 405.430 Failure to properly opt-out. ( a ) A physician or practitioner fails to properly opt-out if— ( 1 ) Any private contract between the physician or practitioner and a Medicare beneficiary, that was entered into before the affidavit described in § 405.420 was filed, does not meet the specifications of § 405.415; or
( 2 ) He or she fails to submit the affidavit(s) in accordance with § 405.420.
( b ) If a physician or practitioner fails to properly opt-out in accordance with paragraph (a) of this section, the following results obtain: ( 1 ) The physician's or practitioner's attempt to opt-out of Medicare is nullified, and all of the private contracts between the physician or practitioner and Medicare beneficiaries for the two-year period covered by the attempted opt-out are deemed null and void.
( 2 ) The physician or practitioner must submit claims to Medicare for all Medicare-covered items and services furnished to Medicare beneficiaries, including the items and services furnished under the nullified contracts. A nonparticipating physician is subject to the limiting charge provisions of § 414.48 of this chapter. A participating physician is subject to the limitations on charges of the participation agreement he or she signed.
( 3 ) The practitioner may not reassign any claim except as provided in § 424.80 of this chapter.
( 4 ) The practitioner may neither bill nor collect an amount from the beneficiary except for applicable deductible and coinsurance amounts.
( 5 ) The physician or practitioner may make another attempt to properly opt-out at any time.